Ultragenyx Pharmaceutical (RARE) Non-Current Assets (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) posted Non-Current Assets of $658 million for Q2 2026, up 12.2% from $586.48 million a year earlier and up 3.0% from the prior quarter.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Non-Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Ultragenyx Pharmaceutical's Non-Current Assets came in at $581 million, down 15.3% from FY2024.
- Annual Non-Current Assets shows a five-year compound annual growth rate of 4.6% (FY2020 to FY2025).
- In prior years, Ultragenyx Pharmaceutical's Non-Current Assets was $686 million in FY2024 (-9.6%), $758.83 million in FY2023 (+14.7%), $661.55 million in FY2022 (-0.6%) and $665.79 million in FY2021 (+43.4%).
- The Q2 2026 figure stands as the highest quarterly Non-Current Assets since Q4 2024.
- On a year-over-year basis, Non-Current Assets increased in three of the last eight quarters, with an average decline of 5.4%.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was Q3 2021, with growth of 60.9%; the weakest was Q3 2025, with a decline of 25.9%.
- According to Business Quant data, Non-Current Assets for the three prior quarters was $639 million (Q1 2026), $581 million (Q4 2025) and $547.24 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Ultragenyx Pharmaceutical | 1.51 Bn | -292.70 Mn | 180.00 Mn | 658.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 658.00 Mn |
| Mar 31, 2026 | 639.00 Mn |
| Dec 31, 2025 | 581.00 Mn |
| Sep 30, 2025 | 547.24 Mn |
| Jun 30, 2025 | 586.48 Mn |
| Mar 31, 2025 | 612.77 Mn |
| Dec 31, 2024 | 686.00 Mn |
| Sep 30, 2024 | 738.76 Mn |
| Jun 30, 2024 | 653.80 Mn |
| Mar 31, 2024 | 711.11 Mn |
| Dec 31, 2023 | 758.83 Mn |
| Sep 30, 2023 | 638.95 Mn |
| Jun 30, 2023 | 609.17 Mn |
| Mar 31, 2023 | 617.07 Mn |
| Dec 31, 2022 | 661.55 Mn |
| Sep 30, 2022 | 605.81 Mn |
| Jun 30, 2022 | 642.09 Mn |
| Mar 31, 2022 | 676.51 Mn |
| Dec 31, 2021 | 665.79 Mn |
| Sep 30, 2021 | 637.92 Mn |
API Access
Ultragenyx Pharmaceutical Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();